Guinea vs Yemen: Population requiring preventive chemotherapy for schistosomiasis
Guinea
4.21 million
in 2024
Yemen
3.85 million
in 2024
Guinea rank
20th
Yemen rank
21st
Population requiring preventive chemotherapy for schistosomiasis over time
- Guinea
- Yemen
How they compare
Guinea currently reports 4.21 million against 3.85 million in Yemen, a difference of 358,970.
That makes Guinea's figure about 1.1 times Yemen's.
The two have swapped places 3 times across 15 shared years of data; in 2010 it was Yemen ahead.
Guinea ranks 20th and Yemen ranks 21st of 52 countries.
Across the 2 decades both report, Guinea averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Guinea | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.98 million | 6.08 million | 3.10 million | Yemen |
| 2020s | 4.42 million | 3.75 million | 668,792 | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Guinea or Yemen?
- Guinea, at 4.21 million against 3.85 million in Yemen as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Guinea and Yemen?
- 358,970, with Guinea ahead.
- How many years of comparable data are there for Guinea and Yemen?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea and Yemen rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Guinea ranks 20th and Yemen ranks 21st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.